Matthew T. Blahna
- Molecular Medicine top 5%
- Cancer Research top 5%
- MicroRNA in disease regulation 4
- Breast Cancer Treatment Studies 2
- Endocrinology top 5%
-
- RNA modifications and cancer 4
- RNA Research and Splicing 3
-
- Advanced Breast Cancer Therapies 2
-
- Urinary Tract Infections Management 2
-
- Immune Response and Inflammation 2
-
- HER2/EGFR in Cancer Research 2
- Co-authors
- Akiko HataJoseph P. MizgerdMatthew R. JonesLee J. QuintonAlexander R. IvanovSuneng FuDieter A WolfJoel R. Neilson
- Journals
- Journal of Biological Chemistry (1 paper)Journal of Clinical Investigation (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesJapanSweden
In The Last Decade
Matthew T. Blahna
13 papers receiving 768 citations
Peers
Comparison fields: 5 of 80
- Molecular Medicine 118
- Cancer Research 309
- Endocrinology 76
- Molecular Biology 467
- Pollution 58
Countries citing papers authored by Matthew T. Blahna
This map shows the geographic impact of Matthew T. Blahna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew T. Blahna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew T. Blahna more than expected).
Fields of papers citing papers by Matthew T. Blahna
This network shows the impact of papers produced by Matthew T. Blahna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew T. Blahna. The network helps show where Matthew T. Blahna may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Matthew T. Blahna, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 7 | |
| 2 | 2023 | 2 | |
| 3 | 2021 | 7 | |
| 4 | 2017 | 21 | |
| 5 | 2013 | 57 | |
| 6 | 2013 | 58 | |
| 7 | 2012 | 66 | |
| 8 | 2012 | 47 | |
| 9 | 2012 | 98 | |
| 10 | 2011 | 17 | |
| 11 | 2009 | 245 | |
| 12 | 2006 | 137 | |
| 13 | 2005 | 19 |
About Matthew T. Blahna
Matthew T. Blahna is a scholar working on Cancer Research, Molecular Medicine and Endocrinology, having authored 13 papers that have together received 781 indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), MicroRNA in disease regulation (4 papers), RNA Research and Splicing (3 papers), Advanced Breast Cancer Therapies (2 papers), Urinary Tract Infections Management (2 papers), Breast Cancer Treatment Studies (2 papers), Immune Response and Inflammation (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Molecular Medicine (118 citations), Cancer Research (309 citations) and Endocrinology (76 citations). Matthew T. Blahna has collaborated with scholars based in United States, Japan and Sweden. Frequent co-authors include Akiko Hata, Joseph P. Mizgerd, Matthew R. Jones, Lee J. Quinton, Alexander R. Ivanov, Suneng Fu, Dieter A Wolf, Joel R. Neilson, Carl F. Marrs and Christy Zalewski. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.